Synpromics Ltd

About:

Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations.

Twitter/X: synpromics

Top Investors: Scottish Enterprise, Calculus Capital, Scottish Investment Bank

Description:

Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.

Total Funding Amount:

9.2M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Edinburgh, Edinburgh, City of, United Kingdom

Founded Date:

2010-01-01

Contact Email:

info(AT)synpromics.com

Founders:

MICHAEL L ROBERTS

Number of Employees:

1-10

Last Funding Date:

2018-05-04

IPO Status:

Private

Industries: